Comparison of HIV-1 mother-to-child transmission after single-dose nevirapine prophylaxis among African women with subtypes A, C, and D [6]

Journal of Acquired Immune Deficiency Syndromes

Volumn 42, Issue 4, 2006, Pages 518-521

  Eshleman, Susan H ^a   Church, Jessica D ^a   Chen, Shu ^b   Guay, Laura A ^a   Mwatha, Anthony ^c   Fiscus, Susan A ^d   Mmiro, Francis ^e   Musoke, Philippa ^e   Kumwenda, Newton ^b   Jackson, J Brooks ^a   Taha, Taha E ^b   Hoover, Donald R ^f  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e MAKERERE UNIVERSITY   (Uganda)

^f RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEVIRAPINE;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; CHILD; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT DISEASE; LETTER; PRIORITY JOURNAL; VERTICAL TRANSMISSION; VIRUS LOAD; VIRUS TRANSMISSION;

AFRICAN CONTINENTAL ANCESTRY GROUP; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; NEVIRAPINE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; REVERSE TRANSCRIPTASE INHIBITORS; VIRAL LOAD;

EID: 33745913647     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000221676.22069.b8     Document Type: Letter

References (13)

1. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-infant transmission of HIV-1 in Kampala, Uganda: HIVNET-012 randomised trial. Lancet. 1999;354:795-802.
2. Jackson JB, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18 months follow-up of the HIVNET 012 randomised trial. Lancet. 2003;362:859-868.
3. Eshleman SH, Mracna M, Guay LA, et al. Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012). AIDS. 2001;15:1951-1957.
4. Eshleman SH, Hoover DR, Chen S, et al. Nevirapine (NVP) resistance in women with subtype C, compared to subtypes A and D, after administration of single-dose NVP. J Infect Dis. 2005;192:30-36.
5. Eshleman SH, Guay LA, Mwatha A, et al. Comparison of mother-to-child transmission rates in Ugandan women with subtype A vs D HIV-1 who received single dose NVP prophylaxis: HIVNET 012. J Acquir Immune Defic Syndr. 2005;39:593-597.
6. Taha TE, Kumwenda NI, Hoover DR, et al. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial. JAMA. 2004;292:202-209.
7. Taha TE, Kumwenda NI, Gibbons A, et al. Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trial. Lancet. 2003;362:1171-1177.
8. Tapia N, Franco S, Puig-Basagoiti F, et al. Influence of human immunodeficiency virus type 1 subtype on mother-to-child transmission. J Gen Virol. 2003;84:607-613.
9. Renjifo B, Fawzi W, Mwakagile D, et al. Differences in perinatal transmission among human immunodeficiency virus type 1 genotypes. J Hum Virol. 2001;4:16-25.
10. Renjifo B, Gilbert P, Chaplin B, et al. Preferential in-utero transmission of HIV-1 subtype C as compared to HIV-1 subtype A or D. AIDS. 2004;18:1629-1636.
11. Yang C, Li M, Newman RD, et al. Genetic diversity of HIV-1 in western Kenya: subtype-specific differences in mother-to-child transmission. AIDS. 2003;17:1667-1674.
12. Eshleman SH, Lie Y, Hoover DR, et al. Association of HIV-1 replication capacity with HIV-1 mother-to-child transmission among antiretroviral drug naive Malawian women. J Infect Dis. 2006. In press.
13. Eshleman SH, Gonzales MJ, Becker-Pergola G, et al. Identification of Ugandan HIV-1 variants with unique patterns of recombination in pol involving subtypes A and D. AIDS Res Hum Retroviruses. 2002;18:507-511.